Skip to main content
padlock icon - secure page this page is secure

Free Content Frequency and type of microbiological monitoring of multidrug-resistant tuberculosis treatment

Download Article:
(PDF 263.5 kb)
Monthly culture is usually recommended to monitor treatment of multidrug-resistant tuberculosis (MDR-TB). As mycobacterial laboratory capacity is limited in many settings, TB programs need evidence to decide whether monthly cultures are necessary compared to other approaches. We simulated three alternative monitoring strategies (culture every 2 or 3 months, and monthly smears alone) in a cohort of MDR-TB patients in Estonia, Latvia, Philippines, Russia and Peru from 2000 to 2004. This retrospective analysis illustrated that less frequent testing delays confirmation of bacteriological conversion. This would prolong intensive treatment, hospitalization and respiratory isolation, increasing cost and toxicity. After conversion, less frequent testing could delay diagnosis of possible treatment failure.
No Reference information available - sign in for access.
No Supplementary Data.
No Article Media
No Metrics


Document Type: Short Communication

Affiliations: 1: US Centers for Disease Control and Prevention, Atlanta, GA, USA 2: Partners In Health, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA 3: Partners In Health, Boston, Massachusetts, USA 4: Tartu University Lung Hospital, Tartu, Estonia; 5: World Health Organization, Geneva, Switzerland 6: Infectology Center of Latvia, TB and Lung Diseases Clinic, Riga, Latvia 7: Tropical Disease Foundation, Manila, The Philippines 8: National Institute for Health Development, Tallinn, Estonia

Publication date: November 1, 2011

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.

    Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more